silver acetate has been researched along with Cystic Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cannon, CL; Cho, S; Li, R; Raymond, JE; Shah, PN; Smolen, JA; Wang, H; Wooley, KL; Zhang, F; Zhang, S | 1 |
| Cannon, CL; Coughenour, M; Crosby, SD; Durmus, S; Ely, DL; Hindi, K; Hogue, LA; Hovis, CE; Kascatan-Nebioglu, A; Mallett, RJ; Melaiye, A; Milsted, A; Panzner, MJ; Tessier, CA; Youngs, WJ | 1 |
2 other study(ies) available for silver acetate and Cystic Fibrosis
| Article | Year |
|---|---|
Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infections.
Topics: Acetates; Anti-Bacterial Agents; Bacterial Infections; Biocompatible Materials; Bronchi; Cations; Cystic Fibrosis; Drug Delivery Systems; Drug Design; Epithelial Cells; Humans; Lung Diseases; Metal Nanoparticles; Micelles; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nanotechnology; Polymers; Silver; Silver Compounds; Solubility; Spectrum Analysis, Raman; Water | 2015 |
Synthesis from caffeine of a mixed N-heterocyclic carbene-silver acetate complex active against resistant respiratory pathogens.
Topics: Acetates; Animals; Anti-Bacterial Agents; Antifungal Agents; Caffeine; Cells, Cultured; Crystallography, X-Ray; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Fungal; Gene Expression; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methylation; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Structure; Organometallic Compounds; Respiratory Mucosa; Respiratory Tract Infections; Silver Compounds; Structure-Activity Relationship | 2006 |